Dysgerminoma - 4 Studies Found
Completed |
: Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) : Dysgerminoma : 2005-09-13 : Drug: Darbepoetin alfa |
Recruiting |
: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors :
|
Terminated |
: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer :
|
Completed |
: Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors :
|